T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Match Group
MTCH
|
+$3.17B |
| 2 |
Nike
NKE
|
+$1.94B |
| 3 |
Bank of America
BAC
|
+$1.84B |
| 4 |
FedEx
FDX
|
+$1.78B |
| 5 |
PNC Financial Services
PNC
|
+$1.61B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPLI
People Inc
PPLI
|
+$4.1B |
| 2 |
Fortive
FTV
|
+$2.54B |
| 3 |
Linde
LIN
|
+$1.53B |
| 4 |
Alibaba
BABA
|
+$1.35B |
| 5 |
Willis Towers Watson
WTW
|
+$1.13B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.99% |
| 2 | Healthcare | 16.87% |
| 3 | Consumer Discretionary | 15.81% |
| 4 | Financials | 11.47% |
| 5 | Communication Services | 10.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AKRO
1201
DELISTED
Akero Therapeutics
AKRO
| $15.5M | ﹤0.01% |
502,481
+355,949
| +243% | +$12.4M |
|
|
CCXI
1202
DELISTED
ChemoCentryx, Inc.
CCXI
| $15.4M | ﹤0.01% |
281,162
-351,795
| -56% | -$18.9M |
|
1203
Plains GP Holdings
PAGP
$5.04B
| $15.2M | ﹤0.01% |
2,502,366
+386,269
| +18% | +$2.96M |
|
1204
BorgWarner
BWA
$14B
| $14.8M | ﹤0.01% |
435,240
-15,409
| -3% | -$530K |
|
|
HDS
1205
DELISTED
HD Supply Holdings, Inc.
HDS
| $14.8M | ﹤0.01% |
359,610
-277,978
| -44% | -$10.6M |
|
1206
Everest Group
EG
$13.9B
| $14.7M | ﹤0.01% |
74,598
-2,497
| -3% | -$535K |
|
1207
LKQ Corp
LKQ
$6.25B
| $14.7M | ﹤0.01% |
530,485
-58,082
| -10% | -$1.71M |
|
1208
RGC Resources
RGCO
$225M
| $14.6M | ﹤0.01% |
622,559
+58,278
| +10% | +$1.37M |
|
|
REGI
1209
DELISTED
Renewable Energy Group, Inc.
REGI
| $14.5M | ﹤0.01% |
271,621
+236,171
| +666% | +$8.3M |
|
1210
W.R. Berkley
WRB
$25.9B
| $14.5M | ﹤0.01% |
533,297
-49,284
| -8% | -$1.35M |
|
1211
Supernus Pharmaceuticals
SUPN
$2.74B
| $14.5M | ﹤0.01% |
694,115
-837
| -0.1% | -$19K |
|
1212
Globe Life
GL
$13.8B
| $14.5M | ﹤0.01% |
180,926
-9,104
| -5% | -$727K |
|
1213
Cytokinetics
CYTK
$10.2B
| $14.3M | ﹤0.01% |
+660,154
| New | +$15.4M |
|
|
ECOL
1214
DELISTED
US Ecology, Inc.
ECOL
| $14.3M | ﹤0.01% |
436,553
-153,817
| -26% | -$5.38M |
|
1215
Huntington Ingalls Industries
HII
$12.8B
| $14.2M | ﹤0.01% |
101,056
-48,617
| -32% | -$7.82M |
|
1216
Viatris
VTRS
$18.4B
| $14.2M | ﹤0.01% |
955,965
-49,444
| -5% | -$789K |
|
1217
Grupo Aeroportuario del Pacifico
PAC
$12.4B
| $14.1M | ﹤0.01% |
+174,868
| New | +$12.7M |
|
1218
H.B. Fuller
FUL
$3.24B
| $14.1M | ﹤0.01% |
307,957
-20,941
| -6% | -$989K |
|
|
MCF
1219
DELISTED
Contango Oil & Gas Co.
MCF
| $13.9M | ﹤0.01% |
10,365,869
-468,242
| -4% | -$842K |
|
1220
Steel Dynamics
STLD
$37.7B
| $13.7M | ﹤0.01% |
478,985
-90,953
| -16% | -$2.61M |
|
1221
NRG Energy
NRG
$25.2B
| $13.6M | ﹤0.01% |
441,054
-32,874
| -7% | -$1.09M |
|
1222
Quanta Services
PWR
$101B
| $13.5M | ﹤0.01% |
255,881
-15,579
| -6% | -$725K |
|
1223
Ardelyx
ARDX
$1.01B
| $13.5M | ﹤0.01% |
2,562,245
-230,054
| -8% | -$1.38M |
|
|
ALEX
1224
DELISTED
Alexander & Baldwin
ALEX
| $13.4M | ﹤0.01% |
1,195,246
+19,231
| +2% | +$230K |
|
|
JNPR
1225
DELISTED
Juniper Networks
JNPR
| $13.3M | ﹤0.01% |
619,422
-15,778
| -2% | -$374K |
|
Similar funds
T. Rowe Price Associates's Q3 2020 Portfolio in Review
As of Q3 2020, T. Rowe Price Associates held 2,679 positions worth $864B, up 8.7% from $795B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q3 2020 filing shows 185 new, 873 increased, 1,330 reduced and 90 closed positions. Its largest new stake was nCino: 5,133,240 shares worth $395M. The largest sale was People Inc, an estimated $4.1B.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2020 buy was nCino: 5,133,240 shares worth $395M.
- T. Rowe Price Associates added most to Match Group in Q3 2020, an estimated $3.17B increase.
- T. Rowe Price Associates's biggest Q3 2020 reduction was People Inc, cutting an estimated $4.1B.
- T. Rowe Price Associates fully exited 58.com Inc in Q3 2020, selling an estimated $468M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $864B portfolio in Q3 2020.
- T. Rowe Price Associates opened 185 new positions and closed 90 in Q3 2020.
- T. Rowe Price Associates's portfolio value rose 8.7% quarter-over-quarter to $864B.
Based on T. Rowe Price Associates's 13F filing for Q3 2020, filed 16 Nov 2020.